January 2025
The global rehabilitation robots market size is calculated at USD 430 million in 2024, grew to USD 495.53 million in 2025, and is projected to reach around USD 1776.24 million by 2034. The market is expanding at a CAGR of 15.24% between 2025 and 2034. The rising geriatric population, increasing incidences of injuries, and technological advancements drive the market.
Unlock Infinite Advantages: Subscribe to Annual Membership
Rehabilitation is a service provided to patients to help them retain their daily activities by improving their physical and mental well-being. Rehabilitation robots are devices that train lost body functions caused by neurological or traumatic events. These robots are designed to provide different sensorimotor functions, assist physicians in therapeutic training, and assess patients' sensorimotor performance. These robots are usually used as adjuncts to physical therapy. There are generally two basic types of rehabilitation robots: assistive robots and therapy robots. Assistive robots substitute for lost limb movements, while therapy robots allow patients to perform practice movements aided by the robot.
The increasing incidences of stroke, sports injuries, and other injuries caused by numerous chronic disorders potentiate the demand for rehabilitation robots. Approximately 482,886 people were reported to have sports injuries in 2023. The rising geriatric population is also a major concern as it is more prone to chronic disorders or injuries. Technological advancements drive the latest innovations in rehabilitation robots, promoting market growth. Several government and private organizations provide funding to install or adapt robots in the healthcare setting, boosting the market.
Artificial intelligence (AI) plays a vital role in rehabilitation robots, enhancing their functionality and improving patient outcomes. AI introduces automation in robots, resulting in enhanced efficiency and precision. AI-based sensors enable robots to make decisions, providing physical and cognitive support to patients. AI and machine learning (ML) algorithms predict patient treatment outcomes, safety, and user satisfaction. AI refines the movement coordination of robots, augmenting the potential for more efficient and tailored therapeutic interventions. It provides real-time monitoring of patients and aids in personalized treatment regimens. Hence, integrating AI into rehabilitation robots increases the accessibility and affordability of patients. However, there are some challenges, such as the need to design for interoperability and additional privacy risks, which are to be resolved.
Rising Incidences of Neurological Disorders
The major growth factor of the rehabilitation robots market is the rising incidences of neurological disorders. Some common neurological disorders include stroke, dementia, multiple sclerosis, epilepsy, spinal cord injury, and amyotrophic lateral sclerosis. These neurological disorders primarily affect the sensorimotor nerve functions of an individual, making it difficult for the patients to perform daily activities. These disorders are a rising concern due to the growing geriatric population globally. These neurological disorders result in long-term disability, necessitating improvements in the recovery of neurological functions. Rehabilitation robots harness the power of neuroplasticity in humans and enable them to get more out of their rehabilitation. Exoskeletons are robotic devices that attach around to a human body and provide mechanical power to aid in movement, presenting opportunities for people with neurological disorders.
High Cost
The major challenge faced by the market is the high cost of rehabilitation robots. These robots cost thousands of dollars, which limits the affordability of many people from low- and middle-income groups. The high cost of robots also restricts their adoption by several hospitals or rehab centers in underdeveloped and developing countries.
Latest Innovations
The future of the rehabilitation robots market is promising, driven by the latest innovations in robots. The advent of advanced technologies supports the latest innovations. AI, ML, and sensor-based technologies provide innovative solutions and enhance individuals' recovery. Numerous researchers are developing wearable devices to assist individuals with their daily functions. The increasing investments by various government and private organizations encourage researchers to develop more advanced rehab robots. The rapidly expanding neuroscience sector has led to the development of computer chips that can be implanted into a patient’s brain. The functions thought by a patient can then be executed through rehab robots. Thus, the latest innovations provide personalized treatment and care to patients.
By type, the exoskeleton segment held a dominant presence in the rehabilitation robots market in 2024. The exoskeleton is a wearable robot device that provides ergonomic support to the human body and delivers mechanical power to aid movement. The widespread applications in the healthcare sector and burgeoning robotic sector boost the segment’s growth. They are predominantly used to train muscle movements and assist in injury recovery. The rising prevalence of neurological disorders and orthopedic injuries also potentiates the segment’s growth.
By type, the therapy robots segment is anticipated to grow with the highest CAGR in the rehabilitation robots market during the studied years. Therapy robots are devices that help patients regain motor functions and recover from injuries and disorders. These devices are designed to perform precise and controlled movements. The growing demand for personalized therapy and the rising prevalence of injuries such as sports-related injuries promote the segment’s growth. The demand for therapy robots is also high owing to their benefits, which include safety and risk reduction, access and availability, and precision and control. Therapy robots facilitate repetitive, intensive, and exercise-specific training, reducing the burden on therapists.
By extremity, the lower body segment held the largest share of the rehabilitation robots market in 2024. Lower limb rehabilitation helps patients with mobility and rehabilitation assistance for different joints, gait, and daily life activities. The growing research and development activities and increasing lower limb injuries fuel the segment’s growth. Lower limb rehabilitation devices are mostly used for physical or orthopedic injuries. It is estimated that around 215.9 patients per 100,000 patients per year suffer from lower limb long bone fractures. Hip and ankle fractures are the most common lower limb fractures.
By extremity, the upper body segment is projected to expand rapidly in the market in the coming years. Upper body rehabilitation helps patients by assisting in the repetitive, labor-intensive manual therapy that therapists normally administer. Hence, this significantly reduces the time therapists spend providing state-of-the-art treatment. The increasing prevalence of stroke, spinal cord injuries, and other neurological disorders potentiates the demand for upper-body rehabilitation robots.
By end-use, the hospitals & clinics segment led the global rehabilitation robots market in 2024. Hospitals and clinics have the desired facilities and the presence of skilled professionals to operate such complex rehabilitation medical devices, contributing to the segment’s growth. They also have suitable capital investments to adopt novel and advanced devices, providing better treatment. They also possess specialized equipment and favorable regulatory frameworks. Hospitals & clinics conduct ongoing clinical trials to benefit patients using novel devices before market approval at affordable prices. The segmental growth is also attributed to favorable reimbursement policies, increasing the accessibility of rehabilitation.
By end-use, the senior care facilities segment is predicted to witness significant growth in the market over the forecast period. The rising geriatric population is a major growth for the segment. The geriatric population is more prone to developing chronic disorders compared to other age groups. Favorable government policies support the operation and maintenance of senior care facilities and provide provisions to launch more such facilities.
North America dominated the global rehabilitation robots market share by 46% in 2024. The rising geriatric population, the presence of key players, and advanced healthcare infrastructure drive the market. The U.S. reported 59.2 million people of more than 65 years in 2023. In Canada, more than 7.2 million people were 65 years and above as of mid-2024. The National Institute of Health provides sufficient funding to promote the development of novel rehab robots in the U.S. The U.S. government offers reimbursement policies through Medicaid and Medicare. The increasing collaborations, partnerships, and mergers & acquisitions also contribute to the market.
Asia-Pacific is expected to grow at the fastest rate in the rehabilitation robots market during the forecast period. The increasing incidences of chronic disorders, rising adoption of advanced technologies, and increasing investments drive the market. The growing research and development activities in universities from China and other parts of Asia serve specific rehabilitation needs. The Chinese local governments launched policies to level up the innovation and deployment of robots for future industries, including healthcare. The Japanese government has allocated funds to advance elder care robots, aiming to address a deficit of 380,000 specialized personnel by 2025. The rapidly increasing population and the growing demand for elderly care services are anticipated to promote the use of robots in rehabilitative care.
Zen Koh, Co-founder and Global Hub CEO of Fourier Intelligence, commented that current neurorehabilitation models primarily rely on extended hospital stays or regular therapy sessions, requiring physical interactions between rehab professionals and patients. Hence, the company developed ArmMotus EMU, which is equipped with clinical intelligence and provides personalized therapy, technology-based solutions, coaching capabilities, and remote monitoring.
By Type
By Extremity
By End-Use
By Region
January 2025
January 2025
January 2025
January 2025